Autoantibodies Signal Reduced Cancer Risk in Dermatomyositis Autoantibodies Signal Reduced Cancer Risk in Dermatomyositis

In patients with dermatomyositis positive for anti-TIF1- γ autoantibodies, the presence of anti-CCAR1 autoantibodies indicate normal rather than elevated cancer risk.Medscape Medical News

Source: Medscape Allergy Headlines - February 17, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news